Oracle Investment Management as of March 31, 2022
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 26 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biohaven Pharmaceutical Holding | 46.3 | $247M | 2.1M | 118.57 | |
| Quidel Corporation | 15.5 | $83M | 735k | 112.46 | |
| BioCryst Pharmaceuticals (BCRX) | 6.9 | $37M | 2.3M | 16.26 | |
| Opko Health (OPK) | 6.3 | $34M | 9.7M | 3.44 | |
| Agenus Com New (AGEN) | 4.0 | $21M | 8.7M | 2.46 | |
| Ark Etf Tr Innovation Etf (ARKK) | 3.1 | $17M | 250k | 66.29 | |
| ACADIA Pharmaceuticals (ACAD) | 2.9 | $16M | 646k | 24.22 | |
| Dermtech Ord ord (DMTK) | 2.3 | $12M | 847k | 14.68 | |
| Sema4 Holdings Corp Com Cl A | 2.3 | $12M | 3.9M | 3.07 | |
| Pacific Biosciences of California (PACB) | 2.1 | $11M | 1.2M | 9.10 | |
| Forian Ord (FORA) | 1.6 | $8.8M | 1.3M | 6.96 | |
| Contrafect Corp Com New | 1.3 | $7.1M | 2.0M | 3.65 | |
| Antares Pharma | 1.3 | $7.1M | 1.7M | 4.10 | |
| Accelr8 Technology | 0.7 | $3.9M | 2.7M | 1.44 | |
| Codiak Biosciences | 0.6 | $3.2M | 505k | 6.27 | |
| Immutep Sponsored Ads (IMMP) | 0.5 | $2.7M | 976k | 2.74 | |
| Immunitybio (IBRX) | 0.4 | $2.2M | 400k | 5.61 | |
| Aspira Womens Health | 0.4 | $2.2M | 2.1M | 1.04 | |
| Direxion Shs Etf Tr Sp Biotch Bl New Put Option | 0.3 | $1.8M | 1.0M | 1.77 | |
| Centene Corporation Put Option (CNC) | 0.3 | $1.5M | 300k | 4.95 | |
| Pfizer Put Option (PFE) | 0.2 | $1.3M | 550k | 2.30 | |
| Vertex Energy (VTNR) | 0.1 | $547k | 55k | 9.95 | |
| Biogen Idec (BIIB) | 0.1 | $508k | 2.4k | 210.61 | |
| Soleno Therapeutics Com New | 0.1 | $475k | 2.1M | 0.22 | |
| Arbutus Biopharma (ABUS) | 0.0 | $149k | 50k | 2.98 | |
| Protagenic Therapeutics | 0.0 | $16k | 20k | 0.80 |
